HUP0300386A3 - New (aminopropyl) methylphosphinic acids - Google Patents

New (aminopropyl) methylphosphinic acids

Info

Publication number
HUP0300386A3
HUP0300386A3 HU0300386A HUP0300386A HUP0300386A3 HU P0300386 A3 HUP0300386 A3 HU P0300386A3 HU 0300386 A HU0300386 A HU 0300386A HU P0300386 A HUP0300386 A HU P0300386A HU P0300386 A3 HUP0300386 A3 HU P0300386A3
Authority
HU
Hungary
Prior art keywords
aminopropyl
new
methylphosphinic
acids
methylphosphinic acids
Prior art date
Application number
HU0300386A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0300386A2 publication Critical patent/HUP0300386A2/hu
Publication of HUP0300386A3 publication Critical patent/HUP0300386A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300386A 1999-12-09 2000-12-04 New (aminopropyl) methylphosphinic acids HUP0300386A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904507A SE9904507D0 (sv) 1999-12-09 1999-12-09 New compounds
PCT/SE2000/002427 WO2001041743A1 (en) 1999-12-09 2000-12-04 New (aminopropyl)methylphosphinic acids

Publications (2)

Publication Number Publication Date
HUP0300386A2 HUP0300386A2 (hu) 2003-07-28
HUP0300386A3 true HUP0300386A3 (en) 2005-08-29

Family

ID=20418062

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300386A HUP0300386A3 (en) 1999-12-09 2000-12-04 New (aminopropyl) methylphosphinic acids

Country Status (26)

Country Link
US (1) US6596711B1 (enExample)
EP (1) EP1239843A1 (enExample)
JP (1) JP2003516346A (enExample)
KR (1) KR100752010B1 (enExample)
CN (1) CN1200713C (enExample)
AR (1) AR033350A1 (enExample)
AU (1) AU780259B2 (enExample)
BR (1) BR0016291A (enExample)
CA (1) CA2393510A1 (enExample)
CO (1) CO5261538A1 (enExample)
CZ (1) CZ20021984A3 (enExample)
EE (1) EE200200287A (enExample)
HU (1) HUP0300386A3 (enExample)
IL (2) IL150090A0 (enExample)
IS (1) IS6409A (enExample)
MX (1) MXPA02005537A (enExample)
NO (1) NO20022729L (enExample)
NZ (1) NZ519377A (enExample)
PL (1) PL357115A1 (enExample)
RU (1) RU2267495C2 (enExample)
SE (1) SE9904507D0 (enExample)
SK (1) SK7632002A3 (enExample)
TW (1) TWI225415B (enExample)
UA (1) UA73149C2 (enExample)
WO (1) WO2001041743A1 (enExample)
ZA (1) ZA200204122B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
TW200407110A (en) * 2001-11-23 2004-05-16 Astrazeneca Ab New use for the treatment of gastroesophageal reflux disease
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
DE10305463A1 (de) * 2003-02-04 2004-08-12 Schering Ag Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
AU2006327315A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
AU2006327317B2 (en) 2005-12-23 2010-11-25 Astrazeneca Ab GABA-B receptor modulators
US8026384B2 (en) 2007-05-04 2011-09-27 Astrazeneca Ab Process for the synthesis of alkyl phosphinic acids by initiation of an amine and an amineoxide
CN101743011A (zh) * 2007-07-25 2010-06-16 阿斯利康(瑞典)有限公司 (3-氨基-2-氟丙基)次膦酸用于治疗非糜烂性反流病的用途
WO2009082344A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
EP2235027A4 (en) * 2007-12-21 2011-06-22 Astrazeneca Ab NEW CRYSTALLINE FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID
JP2011026260A (ja) * 2009-07-28 2011-02-10 Central Glass Co Ltd ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
SU643510A1 (ru) * 1975-04-11 1979-01-25 Предприятие П/Я А-7815 Способ получени о-аминофениларилфосфиновых кислот
SU589756A1 (ru) * 1976-01-23 1982-10-07 Институт Органической Химии Ан Усср Способ получени солей перфторалкилфосфиновых кислот
GB8425872D0 (en) 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
WO1987004077A1 (en) 1986-01-03 1987-07-16 The University Of Melbourne Gastro-oesophageal reflux composition
GB8820266D0 (en) 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
FR2663934B1 (fr) 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
FR2722192A1 (fr) 1994-07-06 1996-01-12 Adir Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en) 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
SE9603408D0 (sv) 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
RU2267495C2 (ru) 2006-01-10
WO2001041743A1 (en) 2001-06-14
CA2393510A1 (en) 2001-06-14
CN1200713C (zh) 2005-05-11
CZ20021984A3 (cs) 2002-11-13
SE9904507D0 (sv) 1999-12-09
NO20022729L (no) 2002-07-09
EP1239843A1 (en) 2002-09-18
IL150090A (en) 2006-08-01
PL357115A1 (en) 2004-07-12
HUP0300386A2 (hu) 2003-07-28
KR20020060993A (ko) 2002-07-19
IS6409A (is) 2002-06-06
IL150090A0 (en) 2002-12-01
RU2002113916A (ru) 2004-01-10
AU2241201A (en) 2001-06-18
ZA200204122B (en) 2003-10-29
EE200200287A (et) 2003-08-15
TWI225415B (en) 2004-12-21
BR0016291A (pt) 2002-08-13
AU780259B2 (en) 2005-03-10
KR100752010B1 (ko) 2007-08-28
US6596711B1 (en) 2003-07-22
UA73149C2 (en) 2005-06-15
AR033350A1 (es) 2003-12-17
JP2003516346A (ja) 2003-05-13
NO20022729D0 (no) 2002-06-07
SK7632002A3 (en) 2003-03-04
MXPA02005537A (es) 2004-09-10
NZ519377A (en) 2003-11-28
HK1053066A1 (en) 2003-10-10
CN1413104A (zh) 2003-04-23
CO5261538A1 (es) 2003-03-31

Similar Documents

Publication Publication Date Title
HUP0300301A3 (en) New aminopropylphosphinic acids
HUP0204092A3 (en) Novel bisamidate phosphononate prodrugs
IL150090A0 (en) New (aminopropyl)methylphosphinic acids
AU3022701A (en) Dehydroamino acids
GB9912852D0 (en) Peptides
HUP0202384A3 (en) Substituted phenoxyacetic acids
AU1497802A (en) Ss-thio-amino acids
GB9914135D0 (en) Manufacturing apparatus
EP1147130A4 (en) ALPHA-conotoxin PEPTIDE
GB0007602D0 (en) Cycles
IL144376A0 (en) Peptides
HK1047711A (en) New (aminopropyl)methylphosphinic acids
TW414133U (en) Magnetic socket
SI1317426T1 (sl) Beta-tio-aminokisline
CA92102S (en) Figurine
GB9904668D0 (en) Glyphosate fprmulation
GB9913845D0 (en) The bouncy shoe
GB9918606D0 (en) Novel peptides
GB9918596D0 (en) Novel peptides
GB9918604D0 (en) Novel peptides
GB9918598D0 (en) Novel peptides
GB9918593D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides
GB9918595D0 (en) Novel peptides
GB9918603D0 (en) Novel peptides

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished